A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neutropenia|Febrile Neutropenia
Interventions: DRUG: Drug: Pegylated rhG-CSF: 100µg/kg|DRUG: Pegylated rhG-CSF: 6mg|DRUG: rhG-CSF 5ug/kg/day
Sponsor: Jiangsu HengRui Medicine Co., Ltd.